Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
PLx Pharma Inc.

PLx Pharma Inc. (PLXP) Stock Overview

Explore PLx Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

PLXP●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.09
$0.00(0.00%)
U.S. Market is Open · 13:55

PLx Pharma Inc. (PLXP)

Meyka AI Score

Z

Key Financials

Market Cap2.5M
P/E Ratio-0.04
EPS (TTM)$-0.39
ROE-1.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PLXP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of PLx Pharma Inc. (NASDAQ: PLXP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, PLx Pharma Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PLXP on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind PLx Pharma Inc.'s NASDAQ-traded stock include a P/E ratio of -0.04 and a market capitalization of 2.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PLXP on the NASDAQ.

Price Performance (NASDAQ: PLXP)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-67.17%
6-Month Change
-76.80%
Year-to-Date (YTD) Change
-53.72%
1-Year Change
-95.71%
3-Year Change
-96.95%
5-Year Change
-98.02%
All-Time (Max) Change
-99.92%

Contact Information

https://gleam-bikes.com/de
973 409 6541
9 Fishers Lane, Sparta, NJ, 07871

Company Facts

160 Employees
IPO DateMar 13, 2014
CountryUS

Frequently Asked Questions